LND topic: recursion-pharmaceuticals page 1

recursion pharmaceuticals

Cathie Wood's Bold Moves in a Shaky Crypto Market

December 18, 2025

Cathie Wood's Ark Invest made some big moves in the crypto world recently. They bought a lot of shares in Bitmine Immersion, Coinbase, and Bullish. But they also sold some shares in Shopify and a few other companies. This all happened while Bitcoin and Ethereum were losing value. Bitmine Immersion

business

Stocks on the Move: A Midday Market Roundup

December 17, 2025

The stock market was buzzing with activity at midday, with several companies seeing significant shifts in their share prices. Texas Pacific Land caught the eye of investors, with its shares climbing 8% after teaming up with Bolt Data & Energy. This collaboration aims to build large-scale data center

health

More Women Can Now Use the Libido Drug Addyi

December 16, 2025

The FDA has recently given the green light to a wider group of women to use Addyi, a drug designed to boost sexual desire. This time, the approval is for postmenopausal women up to 65 years old. Addyi was first introduced a decade ago for premenopausal women dealing with emotional stress due to a lo

health

Helping Chonky Cats Slim Down: A New Drug on the Horizon

December 15, 2025

Cats are often seen as majestic creatures, but when they become "chonky, " it's not just cute—it's a health risk. Over half of the world's pet cats are overweight, which can lead to serious issues like diabetes, arthritis, and heart problems. Losing weight is tough for cats, and it's not just about

finance

Healthcare Investors Bet Big Against the Market

December 12, 2025

In November, the healthcare sector of the S&P 500 saw a notable increase in short selling. The average short interest jumped from 1. 97% to 2. 12%. This means more investors are betting against the sector's future performance. Leading the pack, Moderna (MRNA) remains the most shorted stock in this g

politics

Why Do Public Transit Agencies Need Lobbyists to Be Heard?

November 25, 2025

In a democracy, citizens elect representatives to make decisions. But over time, lobbyists have stepped in to push for specific causes. Some of these causes are important, like medical research or environmental protection. Others are more about business interests, like mining or pharmaceuticals. Lo

finance

Cathie Wood's Big Moves: Tech, Crypto, and Biotech in Focus

November 22, 2025

Cathie Wood's ARK Invest made some bold moves on November 20, shaking up its portfolio with new investments and trimming some existing ones. The spotlight was on Nvidia, a major player in the chip industry, after its impressive third-quarter performance. ARK Invest snapped up 93, 374 shares of Nvidi

business

A Boston Biotech's Big Changes: Jobs Cut, Future Unclear

November 20, 2025

A Boston-based biotech company, Sensei Biotherapeutics, is going through some major changes. They have let go of most of their workers. This is not the first time they have done this. They did something similar last year. Now, they are thinking about selling the company. Sensei Biotherapeutics is f

business

Specialized Freight: The Extra Mile in Logistics

November 19, 2025

In a world where time and safety are crucial, not all shipments are the same. Werner Premium Services steps up to handle the toughest logistics challenges. This isn't just about moving goods; it's about moving them with care, precision, and a deep understanding of each client's unique needs. Werner

health

The Pink Pill: A Journey Through Women's Sexual Health

November 16, 2025

Cindy Eckert, a woman who loves pink, is the CEO of Sprout Pharmaceuticals. Her company makes a drug called Addyi, which helps women with low sex drive. This condition is known as hypoactive sexual desire disorder (H. S. D. D. ). Addyi is often called the "little pink pill" and is different from Via